1816
E. Ramesh, R. Raghunathan / Tetrahedron Letters 49 (2008) 1812–1817
column chromatography (100–200 mesh) using hexane–ethyl acetate
References and notes
(8:2) as eluent.
Compound 4a: Pale yellow solid, mp: 152 °C; 1H NMR (400 MHz,
CDCl3): 1.75 (s, 3H), 2.01 (s, 3H), 3.41 (s, 3H), 3.78 (s, 3H ), 5.18 (d,
J = 4.5 Hz, 2H), 5.33 (t, J = 4.5 Hz, 1H), 7.38 (s, 1H), 9.49 (s, 1H);13C
NMR (100 MHz, CDCl3): d 20.2, 24.3, 30.4, 30.1, 32.4, 104.8, 117.7,
117.9, 130.9, 132.2, 150.4, 158.8, 147.5, 178.6; MS (EI) m/z: 275 (M+);
Anal. Calcd for C14H17N3O3: C, 61.09; H, 6.18; N, 15.27. Found: C,
60.77; H, 6.14; N,15.23.
Compound 4b: Pale yellow solid, mp: 170 °C; 1H NMR (400 MHz,
CDCl3): d 3.42 (s, 3H), 3.82 (s, 3H), 5.54 (d, J = 4.8 Hz, 2H), 6.22 (d,
J = 16.1 Hz 1H ), 6.35 (dt, J = 16.1 Hz, 1H), 7.02–7.73 (m, 5H), 7.45
(s, 1H), 9.58 (s, 1H); 13C NMR (100 MHz, CDCl3): d 29.5, 33.6, 31.5,
104.5, 117.7, 126.4 128.0, 128.7, 128.9, 130.5, 131.0, 133.2, 133.4,
135.2, 146.6, 150.1, 157.3, 178.3 ppm; MS (EI) m/z: 323 (M+); Anal.
Calcd for C18H17N3O3: C,66.87; H, 5.26; N, 13.00. Found: C, 66.77;
H, 5.23; N, 13.14.
1. Boger, D. L.; Weinreb, S. M. In Hetero Diels–Alder Methodology in
Organic Synthesis; Wasserman, H. H., Ed.; Academic Press: San
Diego, 1987; Vol. 47, pp 167–204.
2. Jørgensen, K. A. Angew. Chem., Int. Ed. 2000, 39, 3558–3588.
3. Roush, W. R. J. Am. Chem. Soc. 1978, 100, 3599–3601.
4. Roush, W. R.; Peseckis, S. M. J. Am. Chem. Soc. 1981, 103, 6696–
6701.
5. Ellis, G. P.; Lockhart, I. M.; Meeder-Nycz, D.; Schweizer, E. E. In
Chromenes, Chromanones and Chromones; Ellis, G. P., Ed.; John
Wiley and Sons, 1997.
6. Feuer, G. In Progress in Medicinal Chemistry; Ellis, G. P., West, G.
B., Eds.; North-Holland Publishing Co.: New York, 1974.
7. Deana, A. A. J. Med. Chem. 1983, 26, 580–585.
8. Wenkert, E.; Buckwalter, B. L. J. Am. Chem. Soc. 1972, 94, 4367–
4369.
9. Kostova, I. Curr. Med. Chem.–Anti-Cancer Agents 2005, 5, 29–46.
10. Barr, S. A.; Neville, C. F.; Grundon, M. F.; Boyd, D. R.; Malone, J.
F. I.; Evans, T. A. J. Chem. Soc., Perkin Trans. 1 1995, 445–452.
11. Ahmad, S. J. Nat. Prod. 1985, 47, 391–392.
25. Rathna Durga, R.; Jayashankaran, J.; Raghunathan, R. Tetrahedron
2006, 62, 12357–12362.
26. Ramesh, E.; Kathiresan, M.; Raghunathan, R. Tetrahedron Lett.
2007, 48, 1835–1839.
27. General procedure for the intramolecular domino Knoevenagel–hetero
Diels–Alder reaction: Method A: To a refluxing solution of unsym-
metrical 1,3-dione (1 mmol) in 10 mL of dry toluene, aldehyde 4a or
4b (1 mmol) was added and the reaction mixture was refluxed until the
disappearance of the starting material as evidenced by thin layer
chromatography. After completion of the reaction, the solvent was
evaporated and the residue was subjected to flash column chroma-
tography using hexane/ethyl acetate (7:3).
12. Mitaku, S.; Skaltsounis, A. L.; Tillequin, F.; Koch, M.; Pusset, J.;
Chauviere, G. J. Nat. Prod. 1985, 48, 772–773.
13. Buslig, B. S., Ed.Flavonoids in Living Systems: Advances in Exper-
imental Medicine and Biology; Manthy, J. A., Ed.; Plenum: New
York, 1998; Vol. 439.
14. Korkina, G. L.; Afanas’ev, I. B. In Sies, H., Ed.; Adv. Pharmacol.
1997, 38, 151.
15. Groundwater, P. W.; Solomon, K. R. H.; Drewe, J. A.; Munawar, M.
A. In Progress in Medicinal Chemistry; Ellis, G. P., Luscombe, D. K.,
Eds.; Elsevier: Amsterdam, 1996; Vol. 33, p 233.
16. Negwer, M. Organic Chemical Drugs and their Synonyms, 7th ed.;
Akademie: Stuttgart, 1994.
17. Varaprasad, C. V. N. S.; Ramasamy, S. K.; Girardet, J. L.; Gunic, E.;
Lai, V.; Zhong, Z.; An, H.; Hong, Z. Bioorg. Chem. 2007, 35, 25–
34.
18. Srikanth, K.; Debnath, B.; Jha, T. Bioorg. Med. Chem. Lett. 2002, 12,
899–902.
19. Moriarty, K. J.; Koblish, H. K.; Garrabrant, T.; Maisuria, J.; Khalil,
E.; Ali, F.; Petrounia, L. P.; Crysler, C. S.; Maroney, A. C.; Johnson,
D. L.; Galemmo, R. A. Bioorg. Med. Chem. Lett. 2006, 16, 5778–
5783.
Method B: A mixture of unsymmetrical dione (1 mmol) and the
corresponding aldehyde (1 mmol) in dry ethanol was irradiated using
a microwave oven (Kenstar, 600 W power) until the disappearance of
the starting material. After removal of the solvent, the crude reaction
mixture was subjected to flash column chromatography as reported in
method A.
Method C: A mixture of 1,3-dione (1 mmol), the corresponding
aldehyde (1 mmol) and K-10 montmorillonite clay (1.0 g) was
thoroughly ground in a mortar. The reaction mixture was irradiated
with a microwave (600 W) until the disappearance of the starting
material as evidenced by thin layer chromatography. After comple-
tion of the reaction, the clay was separated by filtration and the
product extracted with dichloromethane (2 ꢁ 15 mL). Removal of the
solvent and the purification of the crude reaction mixture by flash
column chromatography gave the pure product.
20. Klump, S.; Frey, M.; Kleefeld, G.; Sauer, A.; Eger, K. Biochem.
Pharmacol. 1989, 38, 949–953.
21. Wade, A. E.; Krawczyk, S. H.; Townsend, B. L. Tetrahedron Lett.
1988, 29, 4073–4076.
7a,15b-cis-6,7-Dihydro-2,4-dioxo-3,5,8,8-tetramethyl-7,7a,8,15b-tetra-
hydropyrimido[2,3-b]pyrrolizino[40,30:4,5] pyrano[5,6-c]coumarin 7a:
;
Yellow solid, mp: 230–232 °C; IR (KBr): 1640 cmꢀ1 1H NMR
22. Edstrom, E. D.; Wei, Y. Tetrahedron Lett. 1994, 35, 8989–8990.
23. Experimental procedure for compound 2: 2,4-Dioxo-tetrahydropyr-
role[2,3-d]pyrimidine 1 (0.01 mol) in DMF (10 mL) was added slowly
with stirring and exclusion of moisture to a mixture of DMF (0.4 mol)
and POCl3 (0.01 mol), keeping the temperature between 20 and 30 °C.
After cooling to 0 °C, the resulting yellow solid was filtered and the
solid was heated with water (10 mL) at 60–80 °C for 45 min. After
cooling, the resulting precipitate was filtered, washed with H2O and
then recrystallized from ethyl acetate. Purple solid, mp: 282 °C 1H
NMR (400 MHz, DMSO): 3.30 (s, 3H), 3.57 (s, 3H), 6.81 (s, 1H), 9.32
(s, 1H), 12.2 (s, 1H, br s).; MS (EI) m/z: 207 (M+); Anal. Calcd for
C9H9 N3O3: C, 52.17; H, 4.38; N, 20.28. Found: C, 51.90; H, 4.41; N,
20.24.
(300 MHz, CDCl3): d 1.51 (s, 3H), 1.58 (s, 3H), 3.32 (s, 3H), 3.36–3.44
(m, 1Hb), 3.62 (s, 3H), 4.16 (dd, J = 7.3, 9.9 Hz, 1H), 4.23 (d,
J = 6.8 Hz, 1Ha), 4.49 (dd, J = 8.4, 9.9 Hz, 1H), 6.65 (s, 1H), 7.21–
7.27 (m, 2H), 7.45–7.51 (m, 2H); 13C NMR (75 MHz, CDCl3): d
25.36, 26.15, 26.40, 28.05, 30.06, 32.60, 45.09, 49.86, 70.40, 76.60,
104.56, 105.80, 121.28, 123.46, 125.4, 128.80, 132.46, 133.30, 138.5,
149.5, 151.40, 158.80, 165.5 ppm; MS (EI) m/z: 419.43 (M+); Anal.
Calcd for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02. Found: C, 66.00;
H, 5.15; N, 9.89.
7a,15b-cis-6,7-dihydro-2,4-dioxo-3,5,8,8-tetramethyl-7,7a,8,15b-tetra-
hydropyrimido[2,3-b]pyrrolizino[40,30:4,5]pyrano[6,5-c]chromone 7b:
;
Yellow solid, mp: 247–249 °C; IR (KBr): 1732 cmꢀ1 1H NMR
(300 MHz, CDCl3): d 1.54 (s, 3H), 1.57 (s, 3H), 3.30 (s, 3H), 3.28–3.35
(m, 1Hb), 3.68 (s, 3H), 4.03 (dd, J = 7.1 Hz, 1H), 4.21(d, J = 6.0 Hz,
1Ha), 4.32 (dd, J = 8.4 Hz, 1H), 6.62 (s, 1H), 7.22–7.37 (m, 2H), 7.35–
7.42 (m, 2H); 13C NMR (75 MHz, CDCl3): d 24.30, 25.05, 24.40,
27.05, 32.16, 31.50, 45.15, 48.80, 69.40, 75.60, 105.50, 111.80, 122.24,
123.36, 125.4, 127.96, 130.46, 134.30, 136.5, 145.5, 153.40, 153.80,
177.1 ppm; MS (EI) m/z: 419.43 (M+); Anal. Calcd for C23H21N3O5:
C, 65.86; H, 5.05; N, 10.02. Found: C, 65.98; H, 5.20; N, 9.87.
24. Experimental procedure for compounds 4a/4b: 1,3-Dimethyl-2,4-dioxo-
1H-pyrrolo[2,3-d]pyrimidine-6-carbaldehyde 2 (10 mmol) in DMF
(20 mL) was treated with solid K2CO3 (16 mmol) and 1-bromo-3-
methylbut-2-ene (12 mmol) or cinnamyl bromide (12 mmol) and the
mixture was stirred overnight at 20 °C. Water (50 mL) was added to
the mixture and the aqueous layer was extracted with ethyl acetate
(4 ꢁ 20 mL).The combined organic layer was dried (MgSO4) and the
solvent was removed in vacuo and the crude product subjected to